Affinia Therapeutics is pioneering advancements in adeno-associated virus (AAV) gene therapy, focusing on the development of transformative medicines. By leveraging innovative biotechnology, the company aims to address unmet medical needs and improve the lives of patients through cutting-edge therapeutic solutions in the biotechnology and life sciences sectors.
Competitors of Affinia Therapeutics are Spark Therapeutics, Bluebird Bio, Voyager Therapeutics, Regenxbio, Sangamo Therapeutics, CureVac, UniQure, GenSight Biologics, AGTC.
What does Affinia Therapeutics do?
Affinia Therapeutics is pioneering advancements in adeno-associated virus (AAV) gene therapy, focusing on the development of transformative medicines. By leveraging innovative biotechnology, the company aims to address unmet medical needs and improve the lives of patients through cutting-edge therapeutic solutions in the biotechnology and life sciences sectors.
What are the social media links of Affinia Therapeutics?
Social media links of Affinia Therapeutics areLinkedIn